Applied Therapeutics, Inc. Proceeds from Warrant Exercises
Applied Therapeutics, Inc. reported Proceeds from Warrant Exercises of $0 for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-13.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromWarrantExercises · last filed 2025-11-13
- Applied Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2025-09-30 was $0.00.
- Applied Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2025-06-30 was $0.00.
- Applied Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Applied Therapeutics, Inc. proceeds from warrant exercises for the quarter ending 2024-12-31 was $0.00.
- Applied Therapeutics, Inc. proceeds from warrant exercises for fiscal 2024 was $9.03M, a 11.95% decline from fiscal 2023.
- Applied Therapeutics, Inc. proceeds from warrant exercises for fiscal 2023 was $10.25M.
- Applied Therapeutics, Inc. proceeds from warrant exercises for fiscal 2021 was $69.00K.
| Period end | Proceeds from Warrant Exercises 3 month | Proceeds from Warrant Exercises 6 month | Proceeds from Warrant Exercises 9 month | Proceeds from Warrant Exercises 12 month |
|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $0.00 10-Q · filed 2025-08-13 | $0.00 derived: sum of 3 quarters · filed 2025-08-13 | $0.00 derived: sum of 4 quarters · filed 2025-11-13 |
| 2025-03-31 | $0.00 10-Q · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-05-14 | $0.00 derived: sum of 3 quarters · filed 2025-11-13 | $0.00 derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $0.00 derived: sum of 3 quarters · filed 2025-11-13 | $9.03M 10-K · filed 2025-04-15 |
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2025-11-13 | $9.03M 10-Q · filed 2025-11-13 | $9.03M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-13 | $9.03M 10-Q · filed 2025-08-13 | $9.03M derived: sum of 3 quarters · filed 2025-08-13 | |
| 2024-03-31 | $9.03M 10-Q · filed 2025-05-14 | $9.03M derived: sum of 2 quarters · filed 2025-05-14 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $10.25M 10-K · filed 2025-04-15 | ||
| 2023-09-30 | $10.25M 10-Q · filed 2024-11-07 | |||
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $0.00 derived: sum of 2 quarters · filed 2023-03-23 | $0.00 derived: sum of 3 quarters · filed 2023-03-23 | $69.00K 10-K · filed 2023-03-23 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $69.00K 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $69.00K 10-Q · filed 2022-08-12 | ||
| 2021-03-31 | $69.00K 10-Q · filed 2022-05-12 |